Channels A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Changes in Subjective Quality of Life and Medication Satisfaction
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms
What does it take to make real‐world changes in schizophrenia care?
An excitement building in the development of psychological treatments for schizophrenia
Quality of Life After Psychosis: Surviving Schizophrenia and Making a Full Emotional Recovery
The new German evidence‐ and consensus‐based schizophrenia guideline
Taking care of psychotic disorders globally, beyond clinical management
Biomarkers in Schizophrenia: Current Approaches and New Developments—A Literature Review
Towards an integrative and personalized care across the stages of schizophrenia spectrum disorders
Interventions in schizophrenia should be transdiagnostic, biologically informed, individualized, and disease modifying
The problem of recognition of clinical high‐risk states is hampering the prevention of schizophrenia
Insights into the origin of DNA methylation differences between monozygotic twins discordant for schizophrenia
Aerobic Exercise for Cognitive and Functional Enhancement in Schizophrenia: Evidence, Mechanisms, and Practical Recommendations
Hydrogen Gas Therapy in Schizophrenia: Potential Neuroprotective Effects From an Animal Study
Effectiveness of Electroconvulsive Therapy in the Remission of Malignant Catatonia Associated With Schizophrenia: A Case Report
Managing Recurrent Postictal Worsening of Psychosis in Clozapine-Treated Schizophrenia: A Case Report
A Systematic Review of the Magnetic Resonance Imaging Literature Investigating the Deficit Syndrome in Schizophrenia
Environmental unpredictability predicts positive social risk taking through neural cognitive control
Mitochondrial complex I and III gene mRNA levels in schizophrenia, and their relationship with clinical features
Association Between Frontotemporal Atrophy and Cognitive Impairment in Patients with Schizophrenia Based on Computed Tomography Imaging
Pilot Study of Behavioral Activation Treatment for Negative Symptoms in Older Adults With Schizophrenia Spectrum Disorder
Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia
Correction to “Burnout and Life Satisfaction among Healthcare Workers Related to the COVID-19 Pandemic (Silesia, Poland)”
The Global Burden of Schizophrenia: Findings from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study
Nuances of Gender Identity for a Transgender Patient Receiving Inpatient Treatment for Paranoid Schizophrenia: A Case Study
